WHO ICTRP trial
A Randomized, Parallel, Double-Blind, Safety Study of Enoxaparin Versus…
PER-046-99 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-046-99 |
|---|---|
| Public title | A Randomized, Parallel, Double-Blind, Safety Study of Enoxaparin Versus Unfractionated Heparin in Tirofiban and Aspirin-Treated Patients With Unstable Angina/Non-Q-Wave Myocardial Infarction |
| Scientific title | A Randomized, Parallel, Double-Blind, Safety Study of Enoxaparin Versus Unfractionated Heparin in Tirofiban and Aspirin-Treated Patients With Unstable Angina/Non-Q-Wave Myocardial Infarction |
| Primary sponsor | MERCK SHARP & DOHME PERÚ S.R.L., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | I |
| Conditions | -I200 Unstable angina -I219 Acute myocardial infarction, unspecified Unstable angina Acute myocardial infarction, unspecified;I200;I219;Unstable angina;Acute myocardial infarction, unspecified |
| Interventions | Group name:Tirofiban + Enoxaparin Type of group;1 N° of participants:300 Intervention(s) description:Patients randomized to tirofiban and enoxaparin will receive a loading dose of tirofiban of 0.4 ug/kg/min over 30 minutes followed by a… |
| Registration date | Mar 26, 1999 |
| Target size | 500 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: